Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02462460 · ClinicalTrials.gov registry record
Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
A clinical trial of Screening Breast MRI in Patients Who Are BRCA Mutation Carriers, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 63
- Enrollment target
- 1
- Study location
NCT02462460 is a study of Screening Breast MRI in Patients Who Are BRCA Mutation Carriers that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 63 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02462460, a study of Screening Breast MRI in Patients Who Are BRCA Mutation Carriers, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a rapid scan of the pancreas and ovaries that could be used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently, Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45 minutes each. The investigators hope to create a rapid pancreatic and ovarian MRI evaluation that can be used as a screening tool that is completed in approximately 15 minutes. They will compare different tools available on modern MRI scanners to see which one reliably offers high quality images of the pancreas and ovaries.
Conditions Studied
Interventions
- DEVICE MRI
- BEHAVIORAL Optional Screening Questionnaire
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2015-06 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02462460
The ClinicalTrials.gov registry entry for NCT02462460 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Screening Breast MRI in Patients Who Are BRCA Mutation Carriers appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT02462460 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02462460 about?
NCT02462460 is a clinical study titled "Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI". The purpose of this study is to create a rapid scan of the pancreas and ovaries that could be used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently, Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45 minutes each. The investi...
What is the current status of trial NCT02462460?
This trial is currently active not recruiting. The enrollment target is 63 participants. The study started on 2015-06. Estimated completion is 2026-06.
What conditions does trial NCT02462460 study?
This clinical trial studies the following conditions: Screening Breast MRI in Patients Who Are BRCA Mutation Carriers.
What interventions are being tested in trial NCT02462460?
The interventions under investigation include: MRI (DEVICE), Optional Screening Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02462460?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02462460 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.